Exploring Kynurenic Acid's Role in Schizophrenia through Innovative Cellular Techniques

Dr. Valentina Mancini (Oxford University) joins AJP Audio to discuss the impact of anticholinergic burden on cognition in patients with schizophrenia.  Afterwards, AJP Editor-in-Chief Dr. Ned Kalin puts the rest of the March issue into context.

• 00:32     Mancini interview
• 02:26     Anticholinergic burden method of action
• 02:58     Balancing the impact of side effects in schizophrenia treatment
• 04:52     Limitations
• 05:34     The need for further studies
• 05:59     Clinical implications
• 06:32     Further research
• 07:01     Trials needed
• 07:54     Kalin interview
• 08:03     Mancini et al.
• 11:23     Tiihonen et al.
• 13:43     Zhou et al.
• 16:28     Omlor et al.
• 18:51     Orhan et al.

Transcript

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online.

How authors may submit their work.

Follow the journals of APA Publishing on Twitter.

E-mail us at ajp@psych.org